Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × pamiparib × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Advanced Malignancies 1

Interventions

Temozolomide 12 Magnetic Resonance Spectroscopy 10 Specimen Handling 7 Radiotherapy 7 Biopsy 5 trametinib 3 pembrolizumab 3 abemaciclib 3 Radiation 3 olaparib 2 erdafitinib 2 dabrafenib 2 X-Rays 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 Ipilimumab 2 Everolimus 2 Cyclophosphamide 2 CLR1404 2 vocimagene amiretrorepvec 1 ulixertinib 1 trastuzumab deruxtecan 1 spartalizumab 1 selinexor 1 ruxolitinib 1 ribociclib 1 pamiparib 1 niraparib 1 lorlatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03749187 2026-03-13

PNOC017

University of California, San Francisco

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡